Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takashi Seto

Showing results (161-170 of 242) with videos related to

Pageof 25
Sort By:
International Journal of Clinical Oncology|May 17, 2024
Phase 2 trial of crizotinib in Japanese patients with advanced NSCLC harboring a MET gene alteration: a Co-MET studyKaname Nosaki, Kiyotaka Yoh, Ryo Toyozawa, et al.
Cancer Science|July 1, 2018
Phase II study of ceritinib in alectinib-pretreated patients with anaplastic lymphoma kinase-rearranged metastatic non-small-cell lung cancer in Japan: ASCEND-9Toyoaki Hida, Takashi Seto, Hidehito Horinouchi, et al.
The Lancet. Oncology|May 4, 2013
CH5424802 (RO5424802) for patients with ALK-rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1-2 studyTakashi Seto, Katsuyuki Kiura, Makoto Nishio, et al.
Lung Cancer (Amsterdam, Netherlands)|July 30, 2013
The first case of lung carcinosarcoma harboring in-frame deletions at exon19 in the EGFR geneGouji Toyokawa, Mitsuhiro Takenoyama, Kenichi Taguchi, et al.
The Lancet. Oncology|March 28, 2017
Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trialToshiaki Takahashi, Takeharu Yamanaka, Takashi Seto, et al.
Lung Cancer (Amsterdam, Netherlands)|March 16, 2021
Final survival results for the LURET phase II study of vandetanib in previously treated patients with RET-rearranged advanced non-small cell lung cancerKiyotaka Yoh, Takashi Seto, Miyako Satouchi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 10, 2014
Tolerability of nintedanib (BIBF 1120) in combination with docetaxel: a phase 1 study in Japanese patients with previously treated non-small-cell lung cancerIsamu Okamoto, Masaki Miyazaki, Masayuki Takeda, et al.
The Tokai Journal of Experimental and Clinical Medicine|April 9, 2013
Anemia affects the quality of life of Japanese cancer patientsIzumi Wasada, Hisae Eguchi, Maya Kurita, et al.
Molecular and Clinical Oncology|September 3, 2019
Multicenter study of zoledronic acid administration in non-small-cell lung cancer patients with bone metastasis: Thoracic Oncology Research Group (TORG) 1017Yoshiro Nakahara, Yukio Hosomi, Masahiko Shibuya, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2006
Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer: results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904)Shinzoh Kudoh, Koji Takeda, Kazuhiko Nakagawa, et al.
Pageof 25

Showing results (161-170 of 242) with videos related to

Sort By:
Pageof 25
International Journal of Clinical Oncology|May 17, 2024
Phase 2 trial of crizotinib in Japanese patients with advanced NSCLC harboring a MET gene alteration: a Co-MET studyKaname Nosaki, Kiyotaka Yoh, Ryo Toyozawa, et al.
Cancer Science|July 1, 2018
Phase II study of ceritinib in alectinib-pretreated patients with anaplastic lymphoma kinase-rearranged metastatic non-small-cell lung cancer in Japan: ASCEND-9Toyoaki Hida, Takashi Seto, Hidehito Horinouchi, et al.
The Lancet. Oncology|May 4, 2013
CH5424802 (RO5424802) for patients with ALK-rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1-2 studyTakashi Seto, Katsuyuki Kiura, Makoto Nishio, et al.
Lung Cancer (Amsterdam, Netherlands)|July 30, 2013
The first case of lung carcinosarcoma harboring in-frame deletions at exon19 in the EGFR geneGouji Toyokawa, Mitsuhiro Takenoyama, Kenichi Taguchi, et al.
The Lancet. Oncology|March 28, 2017
Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trialToshiaki Takahashi, Takeharu Yamanaka, Takashi Seto, et al.
Lung Cancer (Amsterdam, Netherlands)|March 16, 2021
Final survival results for the LURET phase II study of vandetanib in previously treated patients with RET-rearranged advanced non-small cell lung cancerKiyotaka Yoh, Takashi Seto, Miyako Satouchi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 10, 2014
Tolerability of nintedanib (BIBF 1120) in combination with docetaxel: a phase 1 study in Japanese patients with previously treated non-small-cell lung cancerIsamu Okamoto, Masaki Miyazaki, Masayuki Takeda, et al.
The Tokai Journal of Experimental and Clinical Medicine|April 9, 2013
Anemia affects the quality of life of Japanese cancer patientsIzumi Wasada, Hisae Eguchi, Maya Kurita, et al.
Molecular and Clinical Oncology|September 3, 2019
Multicenter study of zoledronic acid administration in non-small-cell lung cancer patients with bone metastasis: Thoracic Oncology Research Group (TORG) 1017Yoshiro Nakahara, Yukio Hosomi, Masahiko Shibuya, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2006
Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer: results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904)Shinzoh Kudoh, Koji Takeda, Kazuhiko Nakagawa, et al.
Pageof 25